Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.34
Delayed Data
As of 3:59pm ET
 +0.17 / +2.37%
Today’s Change
4.00
Today|||52-Week Range
13.49
-2.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$404.6M

Company Description

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Contact Information

Avadel Pharmaceuticals Plc
10 Earlsfort Terrace
Dublin Dublin 02
P:(531) 485-1200
Investor Relations:

Employees

Shareholders

Mutual fund holders9.28%
Other institutional39.22%
Individual stakeholders11.86%

Top Executives

Gregory J. DivisChief Executive Officer & Director
Thomas S. McHughChief Financial & Accounting Officer
David SeidenSenior Medical Director
Jason VaughnSenior Vice President-Technical Operations
Jerad G. SeurerSecretary, General Counsel & Vice President